The global Cell Signaling Market was valued at USD 2.32 billion in 2016 and is projected to reach USD 4.18billion by 2025, growing at a CAGR of 6.75% from 2017 to 2025.
With expansion in Genetic make-up based therapeutics and pharmaceuticals, the role of cell signaling pathways and their mechanism have become significant for the R&D purposes. With prevalence of chronic disorders, the market is expected to grow at a high CAGR.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Rising Incidence of Chronic Diseases
1.2 Availability of Funding for Cell-Based Research
1.3 Technological Advancements in Cell-Based Research Instruments
1.4 Growth of End-Use Industries
2. Market Restraints
2.1 High Cost of Cell Signaling Systems
2.2 Ethical Issues Related to Embryonic Stem Cell Signaling Research
Market Segmentation:
1. Global Cell SignalingMarket, by Product:
1.1 Consumables
1.1.1 Antibodies
1.1.2 Reagents
1.1.3 Assay Kits
1.1.4 Other Consumables
1.2 Instruments
2. Global Cell SignalingMarket, by Signaling Type:
2.1 Endocrine Signaling
2.2 Paracrine Signaling
2.3 Autocrine Signaling
2.4 Juxtacrine Signaling
2.5 Other Signaling Types
3. Global Cell SignalingMarket, by Pathway:
3.1 AKT Signaling Pathway
3.2 AMPK Signaling Pathway
3.3 ErbB/HER Signaling Pathway
3.4 Hedgehog Signaling Pathway
3.5 JAK/STAT Signaling Pathway
3.6 Notch Signaling Pathway
3.7 NF-KB Signaling Pathway
3.8 Other Signaling Pathways
4. Global Cell Signaling Market, by Technology:
4.1 Microscopy
4.2 Flow Cytometry
4.3 Mass Spectrometry
4.4 Western Blotting
4.5 ELISA
4.6 Immunohistochemistry
4.7 Other Technologies
5. Global Cell Signaling Market, by Application:
5.1 Medical applications
5.2 Research applications
5.2.1 Cancer Research
5.2.2 Immunology Research
5.2.3 Stem Cells Research
5.2.4 Other Research Applications
6. Global Cell Signaling Market, by Region:
6.1 North America (U.S., Canada, Mexico)
6.2 Europe (Germany, UK, France, Rest of Europe)
6.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
6.4 Latin America (Brazil, Argentina, Rest of Latin America)
6.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Merck KGaA
2. Thermo Fisher Scientific Inc.
3. Becton, Dickinson and Company
4. Beckman Coulter Inc. (A Subsidiary of Danaher Corporation)
5. Bio-Rad Laboratories, Inc.
6. Perkinelmer, Inc
7. Qiagen N.V.
8. Cell Signaling Technology, Inc.
9. Promega Corporation
10. Bio-Techne Corporation
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Cell SignalingMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL CELL SIGNALINGMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL CELL SIGNALINGMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL CELL SIGNALING MARKET, BY PRODUCT:
5.1 Consumables
5.1.1 Antibodies
5.1.2 Reagents
5.1.3 Assay Kits
5.1.4 Other Consumables
5.2 Instruments
6 GLOBAL CELL SIGNALING MARKET, BY SIGNALING TYPE:
6.1 Endocrine Signaling
6.2 Paracrine Signaling
6.3 Autocrine Signaling
6.4 Juxtacrine Signaling
6.5 Other Signaling Types
7 GLOBAL CELL SIGNALING MARKET, BY PATHWAY:
7.1 AKT Signaling Pathway
7.2 AMPK Signaling Pathway
7.3 ErbB/HER Signaling Pathway
7.4 Hedgehog Signaling Pathway
7.5 JAK/STAT Signaling Pathway
7.6 Notch Signaling Pathway
7.7 NF-KB Signaling Pathway
7.8 Other Signaling Pathways
8 GLOBAL CELL SIGNALING MARKET, BY TECHNOLOGY:
8.1 Microscopy
8.2 Flow Cytometry
8.3 Mass Spectrometry
8.4 Western Blotting
8.5 ELISA
8.6 Immunohistochemistry
8.7 Other Technologies
9 GLOBAL CELL SIGNALING MARKET, BY APPLICATION:
9.1 Medical applications
9.2 Research applications
9.2.1 Cancer Research
9.2.2 Immunology Research
9.2.3 Stem Cells Research
9.2.4 Other Research Applications
10 GLOBAL CELL SIGNALINGMARKET, BY GEOGRAPHY
10.1 Overview
10.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
10.2.1 U.S.
10.2.2 Canada
10.2.3 Mexico
10.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Rest of Europe
10.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
10.5.1 Brazil
10.5.2 Argentina
10.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025
11 GLOBAL CELL SIGNALINGMARKETCOMPETITIVE LANDSCAPE
11.1 Overview
11.2 Company Market Share
11.3 Vendor Landscape
11.4 Key Development Strategies
12 COMPANY PROFILES
12.1 Merck KGaA
12.1.1 Overview
12.1.2 Financial Performance
12.1.3 Product Outlook
12.1.4 Key Developments
12.2 Thermo Fisher Scientific Inc.
12.2.1 Overview
12.2.2 Financial Performance
12.2.3 Product Outlook
12.2.4 Key Developments
12.3 Becton, Dickinson and Company
12.3.1 Overview
12.3.2 Financial Performance
12.3.3 Product Outlook
12.3.4 Key Developments
12.4 Beckman Coulter Inc. (A Subsidiary of Danaher Corporation)
12.4.1 Overview
12.4.2 Financial Performance
12.4.3 Product Outlook
12.4.4 Key Developments
12.5 Bio-Rad Laboratories, Inc.
12.5.1 Overview
12.5.2 Financial Performance
12.5.3 Product Outlook
12.5.4 Key Developments
12.6 Perkinelmer, Inc
12.6.1 Overview
12.6.2 Financial Performance
12.6.3 Product Outlook
12.6.4 Key Developments
12.7 Qiagen N.V.
12.7.1 Overview
12.7.2 Financial Performance
12.7.3 Product Outlook
12.7.4 Key Developments
12.8 Cell Signaling Technology, Inc.
12.8.1 Overview
12.8.2 Financial Performance
12.8.3 Product Outlook
12.8.4 Key Developments
12.9 Promega Corporation
12.9.1 Overview
12.9.2 Financial Performance
12.9.3 Product Outlook
12.9.4 Key Developments
12.10 Bio-Techne Corporation
12.10.1 Overview
12.10.2 Financial Performance
12.10.3 Product Outlook
12.10.4 Key Developments
13 Appendix
13.1 Related Reports
The CRISPR Cell Line Development Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufa...
The Gene Knockdown Stable Cell Line Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsc...
The Cell Line Customization Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, man...
The Cell Line Adaptation Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufa...
The Battery Cell Authentication Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscap...
The Stem Cell Biomanufacturing Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufact...
The CD19-targeted CAR-T Cell Therapy Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ma...
The Osteoarthritis Cell Therapy Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufac...
The Cell Immunotherapy Platform Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufac...
The CHO Cell Line Construction Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ...